Gujarat Kidney And Super Speciality Limited has informed the Exchange about order passed by NCLT approving voluntary revision of Borad report and financial statements
GKSL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Kidney and Super Speciality Limited has disclosed that the National Company Law Tribunal (NCLT) has passed an order approving the company's voluntary revision of its Board report and financial statements. This typically means the company itself approached NCLT seeking permission to correct or restate previously filed financial statements. No specific financial figures, reasons for revision, or restatement details have been provided in the headline. The development points to a corporate governance action involving retrospective changes to reported financials.
For shareholders, this signals that past financial statements are being revised, which may affect previously reported earnings, reserves, or other figures. The market may react cautiously until the revised numbers and reasons for the restatement are made clear, as voluntary restatements can sometimes hint at accounting errors or governance issues.